Your session is about to expire
← Back to Search
Experimental Group for Alcoholism (SEAS Trial)
SEAS Trial Summary
This trial is studying how well two sleep conditions impact emotion reactivity in people with alcohol use disorder the morning after.
- Alcoholism
SEAS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SEAS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the study open to participants aged 20 or above?
"As indicated by the eligibility criteria, only patients aged 25 to 65 are able to participate in this clinical trial. This contrasts with 34 trials for individuals below 18 and 249 studies open for adults older than 65 years old."
To whom does this clinical experiment offer enrollment?
"This research programme is looking to enrol a cohort of 100 individuals between the ages of 25 and 65 who have an alcohol drinking history. The prerequisites for candidacy encompass completing at least 8 years' worth of education, specifying as either male or female; meeting DSM 5 requirements pointing towards an Alcohol Use Disorder with a minimum duration of five years (AUD group) or not displaying any psychiatric disorder symptoms (Control group); and being abstinent from alcohol consumption anywhere between 6 months and 36 months due to findings that REM sleep surfeit is apparent within this window."
Is this research presently accepting participants?
"Per information on clinicaltrials.gov, this trial is currently in the process of seeking participants. It was originally posted on June 9th 2021 and its most recent update was recorded July 16th 2021."
How extensive is the participation of this research project?
"Affirmative. Data available on clinicaltrials.gov attests to the active recruitment of this medical study, which was initially published on June 9th 2021 and last updated on July 16th 2021. A total of 100 participants are sought after at a single site for enrolment into the trial."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger